Subconjunctival bevacizumab for corneal neovascularization in herpetic stromal keratitis.
June 28th, 2008Subconjunctival bevacizumab for corneal neovascularization in herpetic stromal keratitis. PURPOSE: To report an 81-year-old woman with corneal neovascularization secondary to herpetic stromal keratitis treated with subconjunctival bevacizumab and to discuss the role of this novel antiangiogenic treatment. METHODS: Case report and review of medical literature. RESULTS: ...